NMO-IgG Status in Fulminant Inflammatory CNS Demyelinating Disorders

BACKGROUND: The aquaporin-4-specific serum autoantibody, NMO-IgG, is a validated biomarker distinguishing neuromyelitis optica spectrum disorders (NMOSD) from multiple sclerosis (MS). Because fulminant attacks are more common in NMOSD than MS, some suggest that NMO-IgG may be a marker of destructive...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Magaña, Setty M., Pittock, Sean J., Lennon, Vanda A., Keegan, B. Mark, Weinshenker, Brian G., Lucchinetti, Claudia F.
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2742779/
https://ncbi.nlm.nih.gov/pubmed/19667216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.2009.152
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires